ab sciex

..............page:508

Advances in the treatment of rheumatic diseases with etanercept
XIA Guang-tao;WANG Xia;SUN Hong-sheng;ZHANG Yuan-chao;Department of Rheumatology and Immunology;Shandong Provincial Hospital;Shandong University;

..............page:513-518

Advance in clinical research of febuxostat in the treatment of gout
ZHANG Yuan-chao;HU Zhong-dan;YANG Zhao-wen;WANG Wei-yan;Department of Rheumatology and Immunology;Shandong Provincial Hospital;Shandong University;

..............page:519-522

ben kan yi yao zhuan lun zhuan ti yu gao

..............page:522

Research advance of therapy of tolicizumab in rheumatoid arthritis
YANG Zhao-wen;CAO Jin;ZHANG Li-min;ZHANG Yuan-chao;Department of Rheumatology and Immunology;Shandong Provincial Hospital;Shandong University;

..............page:523-526+546

Study of the anti-tumor effects of extract of radix actinidiae chinensis by ethanol combined with CIK against gastric cancer cell lines SGC-7901
CHU Jing;GE Xin-guo;ZHOU Jian;JIANG Jing-ting;Oncology department;Changzhou Hospital of Traditional Chinese Medicine;Center of diagnosis and treatment tumor biology;the first people’s Hospital of Changzhou;

..............page:527-532

Study of whitening effects by tricholoma matsutake and several plants extracts
ZHAO Zhen;WANG Rui-xue;ZHONG Yan;LI Xiao-di;WANG Zhi-yong;State Key Laboratory of New Drug & Pharmaceutical Process;Shanghai Institute of Pharmaceutical Industry;China State Institute of Pharmaceutical Industry;Healthy-star Biological Technology Research and Development Co. LTD;

..............page:533-537

Clinical effect observation and nursing of concurrent chemoradiotherapy combined with oteracil potassium capsule for elderly patients with locally advanced esophageal cancer
LV Shu-lin;Ma Xiao-xia;HANG Da-ming;Department of Radiotherapy;Nantong Tumor Hospital;

..............page:538-541+569

Effect of glutamine enriched total parenteral nutrition on nutritional status and immune function in elderly patients after gastrointestinal surgery
SHEN Hao;GONG Min;TANG Wei-yong;Department of General Surgery;Shanghai Jing’an District Centre Hospital;Shanghai Jing’an Branch of Huashan Hospital Affiliated to Fudan University;

..............page:542-546

Clinical observation of recombinant human activated protein C in the treatment of pediatric septic shock
SHEN Ping;Department of Emergency;Wuxi Children’s Hospital;

..............page:547-549

Retrospect analysis of adverse drug reactions of diammonium glycyrrhizinate
ZHU Fu-ping;LEI Zhao-bao;Department of pharmacy;Fengcheng City People’s Hospital;

..............page:550-552

Clinical observation of liposomal amphotericin B in the treatment of 14 patients with pulmonary mucormycosis
ZHANG Xian-xin;RONG Xue-dong;DUAN Ya-qian;MA Zeng-xia;Department of Respiration;Shandong Provincial Chest Hospital;

..............page:553-555

2014 nian 8 yue quan guo fa ding chuan ran bing yi qing gai kuang

..............page:555

Research progress of peptide-drug conjugate
XIA Jiang-hua;FENG Jun;State Key Laboratory of New Drug & Pharmaceutical Process;Shanghai Institute of Pharmaceutical Industry;China State Institute of Pharmaceutical Industry;

..............page:556-559

Research progress of infusion phlebitis animal model
HE Jin-feng;ZHANG Wen-jing;XU Meng-xue;TANG Shi-xin;WANG Zhuo;Anhui University of Traditional Chinese Medicine;Department of Pharmacy;Changhai Hospital;The Second Military Medical University;

..............page:560-565

HARBIN PHARMACEUTICAL GROUP

..............page:563

XIANJU PHARMA

..............page:564

geng zheng

..............page:565

Relationship between relapse in schizophrenia with disease progression
ZHANG Jie;LU Zheng;Shanghai Mental Health Center;Department of Psychiatry;Tongji Hospital;Tongji University;

..............page:566-569

ya bao yao ye ji tuan gu fen you xian gong si

..............page:566

Effi cacy evaluation of ziprasidone for treatment in schizophrenia
HE Lei-ying;Mental Health Center of Shanghai Jinshan District;

..............page:570-574

fda pi zhun avastin zhi liao qin xi xing wan qi gong jing ai

..............page:575-576

fda pi zhun jardiance zhi liao 2 xing tang niao bing

..............page:575

fda pi zhun xin xing shui mian yao wu belsomra

..............page:575

ou meng pi zhun stivarga(regorafenib) zhi liao wei chang dao jian zhi liu

..............page:576

fda pi zhun cerdelga zhi liao 1 xing ge xie bing

..............page:576

hei se su liu zhi liao yao wei luo fei ni (vemurafenib)

..............page:576-577

shi jie lin chuang yao wu za zhi kang hong shu gan jie yu jiao nang bei kang yi yu yao wu lin chuang ying yong yu yan jiu fen xi zheng wen huo dong qi shi

..............page:578